# DIAGNOS Inc.

Type: Company (DGNOF)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/diagnos-inc
Canonical HTML page: https://gethealthbrief.com/entity/diagnos-inc

## Timeline

- **2026-10-26**: Share Hold Period Expires — Four-month-and-one-day hold period ends, allowing newly issued shares to be freely traded, subject to securities laws.
- **2026-06-25**: Anticipated Settlement Date — Settlement expected to close, with 625,000 shares issued and accrued interest paid in cash.
- **2026-06-18**: Debt-for-Equity Agreements Signed — DIAGNOS signs agreements with two lenders to settle C$125,000 in demand loans via equity issuance.
- **2026-02-26**: Market Reporting — Financial news outlets and analysts begin reporting on the company's performance.
- **2026-02-25**: Earnings Release — DIAGNOS Inc. issues financial results for the latest fiscal period.
- **2026-Q1**: Strategic Expansion — Ongoing rollout of the CARA platform in international markets including Saudi Arabia and Mexico.

## Recent coverage (2 stories)

### DIAGNOS Preserves Cash with C$125K Debt-for-Equity at C$0.20 to Fuel AI Eye Diagnostics
2026-06-21 00:10:37 · Sentiment: Neutral · Impact: 5/10 · Sources: 4

Diagnos Inc. converts C$125K in debt to equity, preserving cash to further develop its AI-powered early detection of eye-related health issues. The move underscores the financial pressures on health AI startups but keeps the clinical mission on track.
Full story: https://gethealthbrief.com/story/diagnos-cash-preservation-ai-eye-diagnostics

### DIAGNOS (DGNOF) Reports Earnings Amid Expanding AI Retinal Screening Demand
2026-02-26 17:30:55 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

DIAGNOS Inc. (OTCMKTS: DGNOF) has released its latest financial results, highlighting the company's ongoing efforts to scale its AI-driven retinal screening platform. The results come as the healthcare industry increasingly adopts automated diagnostic tools to address the global rise in diabetic retinopathy and other vision-threatening conditions.
Full story: https://gethealthbrief.com/story/diagnos-dgnof-earnings-ai-retinal-screening

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.